THURSDAY, Dec. 4, 2025 (HealthDay News) — About 1 in every 8 teenagers show signs of hearing loss by the time they reach 18, ...
Pedmark significantly reduces cisplatin-induced hearing loss in pediatric and AYA patients with non-metastatic solid tumors. The trial confirmed Pedmark's non-interference with cisplatin's antitumor ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback